Working… Menu

Short and Long Term Multiple Outcomes in Persons With Multiple Sclerosis Treated by Fampridine. (FAMPISEP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02849782
Recruitment Status : Completed
First Posted : July 29, 2016
Last Update Posted : February 2, 2021
Information provided by (Responsible Party):
Centre Hospitalier Universitaire de Besancon

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 1, 2019
Actual Study Completion Date : March 1, 2019
Publications of Results:

Publications automatically indexed to this study by Identifier (NCT Number):